Photocatalytic degradation of tetracycline in aqueous systems under visible light irridiation using needle-like SnO2 nanoparticles anchored on exfoliated g-C3N4

Abstract

Abstract Background Pharmaceuticals is one of the groups of contaminants of emerging concern that are resistant to decomposition or removal by most of the existing water and wastewater treatment procedures, hence the need to develop techniques to facilitate the removals of this group of organic contaminants from water systems. In this study, needle-like SnO2 nanoparticles was synthesised and loaded on exfoliated g-C3N4 nanosheet through a hydrothermal method, for use as sensitive visible light induce-photocatalyst for the decomposition of tetracycline in aqueous systems. The synthesised composites was characterized and analysed for the nature of the heterojunction between the SnO2 nanoparticle and g-C3N4 nanosheet using microscopic and spectroscopic techniques. Results The composites were of improved surface properties and enhanced visible-light absorption. The synthesised SnO2/g-C3N4 nanocomposites with various amounts of SnO2 (10–50 mg), employed in the degradation of tetracycline under visible light irradiation, were of good degradation efficiency. The degradation efficiencies of tetracycline by 1 wt.%, 2 wt.%, 3 wt.% and 5 wt.% SnO2/g-C3N4 photocatalyst were 81.54%, 90.57%, 95.90% and 92.15% as compared to g-C3N4 and SnO2 with 40.92% and 51.32% degradation efficiencies. The synergistic interaction between the needle-like SnO2 and exfoliated g-C3N4 nanosheet promoted the separation of photogenerated electron holes pairs, which enhanced their migration rate between SnO2 and g-C3N4 heterojunction, thereby facilitating the degradation of tetracycline. The ·O2− was noted to be the major reactive species in the photocatalytic of the 3 wt.% SnO2/g-C3N4 nanocomposite. Conclusion The fabricated SnO2 nanoparticles anchored on exfoliated g-C3N4 showed good performance for the decomposition of tetracycline in water, with possible application on other pharmaceuticals having same moiety (similar chemical structures).